Serum Long Acting Thyroid Stimulator (Lats) and Lats-Protector (LATS-P) in Graves' Disease Complicated by Localized Myxoedema

Hardisty, C. A.; Munro, D. S.

doi:10.1042/cs060010P

Skip Nav Destination

Article navigation

Conference Abstract| March 01 1981

Serum Long Acting Thyroid Stimulator (Lats) and Lats-Protector (LATS-P) in Graves' Disease Complicated by Localized Myxoedema

C. A. Hardisty;

C. A. Hardisty

1Department of Medicine, Clinical Sciences Centre, Northern General Hospital, Sheffield S5 7AU, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

D. S. Munro

1Department of Medicine, Clinical Sciences Centre, Northern General Hospital, Sheffield S5 7AU, U.K.

Search for other works by this author on:

This Site

PubMed

Google Scholar

Clin Sci (Lond) (1981) 60 (3): 10P.

https://doi.org/10.1042/cs060010P

You do not currently have access to this content.

Don't already have an account? Register

You could not be signed in. Please check your email address / username and password and try again.

Portland Press

Registered address – First Floor, 10 Queen Street Place, London EC4R 1BE
Mailing address – 1 Naoroji Street, London WC1X 0GB

Portland Press Tel
+44 (0)20 3880 2795

Biochemical Society Tel
+44 (0)20 3880 2793
Email: editorial@portlandpress.com

Company no. 00892796
Registered Charity no. 253894
VAT no. GB 523 2392 69

Privacy and cookies
Accessibility

Serum Long Acting Thyroid Stimulator (Lats) and Lats-Protector (LATS-P) in Graves' Disease Complicated by Localized Myxoedema

Article PDF first page preview

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

Cover Image

Serum Long Acting Thyroid Stimulator (Lats) and Lats-Protector (LATS-P) in Graves' Disease Complicated by Localized Myxoedema

Article PDF first page preview

Sign in

Sign in to your personal account

Biochemical Society Member Sign in

Sign in via your Institution

Get Access To This Article

Buy This Article

Cited By

Get Email Alerts

CONNECT

EXPLORE

This Feature Is Available To Subscribers Only